Please use this identifier to cite or link to this item:
Title: Synthesis, biological evaluation and in silico study of bis-thiourea derivatives as anticancer, antimalarial and antimicrobial agents
Authors: Pingaew R.
Sinthupoom N.
Mandi P.
Prachayasittikul V.
Cherdtrakulkiat R.
Prachayasittikul S.
Ruchirawat S.
Prachayasittikul V.
Keywords: 1,1' [1,3 phenylenebis(methylene)]bis[3 (4 bromophenyl)thiourea]
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,3 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (3,5 ditrifluoromethylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 bromophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 chlorophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methoxyphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 methylphenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 nitrophenyl)thiourea]
1,1' [1,4 phenylenebis(methylene)]bis[3 (4 trifluoromethylphenyl)thiourea]
antiinfective agent
antimalarial agent
antineoplastic agent
cytotoxic agent
DNA topoisomerase IV
thiourea derivative
unclassified drug
Achromobacter xylosoxidans
agar dilution
animal cell
antimalarial activity
antimicrobial activity
antineoplastic activity
Bacillus cereus
Bacillus subtilis
binding site
carbon nuclear magnetic resonance
computer model
controlled study
drug potency
drug safety
drug screening
drug structure
drug synthesis
Hep-G2 cell line
human cell
hydrogen bond
infrared spectroscopy
Listeria monocytogenes
mass spectrometry
Micrococcus luteus
minimum inhibitory concentration
molecular docking
MOLT-3 cell line
Plasmodium falciparum
Plesiomonas shigelloides
proton nuclear magnetic resonance
Saccharomyces cerevisiae
selectivity index
Shigella dysenteriae
Staphylococcus epidermidis
Issue Date: 2017
Abstract: Two sets of bis-thioureas including a para series (8–14) and a meta series (4, 5, 15–19), were synthesized and evaluated for their anticancer, antimalarial and antimicrobial activities. Most of the synthesized bis-thioureas, except for analogs 8–11, displayed cytotoxicity against MOLT-3 cell line (IC50 = 1.55–32.32 µM). Derivatives 5, 14, 18 and 19 showed a broad spectrum of anticancer activity. Analogs (4, 5, 8, 13, 14, 18 and 19) exhibited higher inhibitory efficacy in HepG2 cells than the control drug, etoposide. Significantly, bis-trifluoromethyl analog 19 was the promising potent cytotoxic agent (IC50 = 1.50–18.82 µM) with the best safety index (1.64–20.60). Antimalarial activity results showed that trifluoromethyl derivative 18 was the most potent compound (IC50 = 1.92 µM, selective index = 6.86). Antimicrobial activity revealed that bis-thioureas 12, 18 and 19 exhibited selective activity against Gram-positive bacteria and fungi. Promisingly, the bis-trifluoromethyl derivative 19 was the most potent compound in the series and displayed higher potency, against most of the Gram-positive bacteria and fungi, than that of ampicillin, the reference drug. Among the tested strains of microorganisms, compound 19 inhibited the growth of Staphylococcus epidermidis ATCC 12228 and Micrococcus luteus ATCC 10240 with the lowest MIC of 1.47 µM. The findings demonstrated that trifluoromethyl group plays a crucial role in their biological activities. Furthermore, the molecular docking was performed to reveal possible binding modes of the compounds against target proteins. © 2017, Springer Science+Business Media, LLC.
ISSN: 10542523
Appears in Collections:SCOPUS 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.